Loading clinical trials...
Loading clinical trials...
A Single-Dose, Comparative Bioavailability Study of Two Formulations of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions
The purpose of this study is to demonstrate the bioequivalence of divalproex sodium 125 MG delayed release tablets.
Age
18 - No limit years
Sex
MALE
Healthy Volunteers
Yes
Start Date
October 1, 2006
Primary Completion Date
October 1, 2006
Completion Date
October 1, 2006
Last Updated
March 29, 2017
28
ACTUAL participants
Divalproex Sodium
DRUG
Depakote DR Tablets
DRUG
Lead Sponsor
Sandoz
NCT05077904
NCT05667142
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07234695